Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PETROFAC LD Director's Dealing 2019

Oct 7, 2019

5194_dirs_2019-10-07_784e4165-6f3c-47f1-bc9d-5f52c1fbe6e8.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0319P

Petrofac Limited

07 October 2019

7 October 2019

Petrofac Limited (the "Company")

Notification of Transaction by

Persons Discharging Managerial Responsibilities (PDMRs)

Pursuant to the Company's obligation under the Market Abuse Regulation 19, the Company hereby notifies that Alastair Cochran, Chief Financial Officer, became entitled on 7 October 2019 to 16,904 ordinary Shares of US$0.02 each in the Company at nil cost, following the automatic vesting of approximately one third of the Shares awarded to him under the Petrofac Restricted Share Plan on 6 October 2016. 

Mr Cochran now holds 76,154 Shares representing 0.022 per cent of the total voting rights of the Company. He sold 7,957 Shares today at 382.90 pence per Share on the London Stock Exchange to satisfy his tax liability.

The Company's issued share capital consists of 345,912,747 Shares with voting rights. Each Share carries the right to one vote. The Company does not hold any shares in Treasury.

For further information contact:

Alison Flynn, Group Head of Communications

[email protected] 

+44 (0) 207 811 4913

Jonathan Low, Head of Investor Relations

[email protected] 

+44 (0) 207 811 4930

Tulchan Communications Group Ltd                                  

Martin Robinson

Tel: +44 (0) 20 7353 4200

[email protected]

LEI 2138004624W8CKCSJ177

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHCKODPNBDDQKK